Purchase Order 12052119P0007
- Not listed
- The U.S. government awarded a $3,194.98 firm fixed-price purchase order to Genscript USA Inc. on May 5, 2015, for custom gene synthesis services. The contract, with an ultimate completion date of September 30, 2015, was funded by a civilian agency within the Midwest Area and performed at the contractor's facility in Piscataway, New Jersey. No set-aside designation was applied to this award. Genscript USA Inc., a biotechnology company specializing in advanced molecular biology services, has...
- This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $3,943.72 contract is for custom gene synthesis services to support NIAID's biomedical research programs. Genscript, a for-profit organization, has a strong track record of providing specialized molecular biology products and services to...
- This $4,448.22 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for custom protein and DNA synthesis services to support biomedical research and public health initiatives. Genscript specializes in providing a range of molecular biology products and services, including gene...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $10,982.04 contract is for the provision of customized protein services, gene synthesis, and other molecular biology products and services to support biomedical research and public health initiatives. The contract does not...
- This federal contract award was issued by the Midwest Area component of a civilian federal agency to Genscript USA Inc., a biotechnology company based in New Jersey. The $13,420.52 firm fixed-price purchase order is for the supply of proteins and antibodies. The contract does not have a set-aside designation. Genscript is a provider of specialized molecular biology products and services to various government agencies, including the Department of Health and Human Services, Department of...
- The U.S. Department of Agriculture's Midwest Area awarded a $3,371.61 firm fixed-price purchase order to Genscript USA Inc. for protein sequencing services on May 18, 2015, with completion targeted for May 31, 2016. The contract, issued without a set-aside designation, leverages Genscript's specialized capabilities in molecular biology and protein production to support federal research initiatives. Performance will be executed at the contractor's facility in Piscataway, New Jersey. Genscript USA...
- This federal contract award to Genscript USA Inc., a biotechnology company based in New Jersey, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,196.16 firm fixed-price purchase order is for gene synthesis services. Genscript, a for-profit organization, has a history of providing a wide range of molecular biology products and services to...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company, for custom gene synthesis services. The contract has a potential value of $21,275.80 and a completion date of August 19, 2020. Genscript, based in Piscataway, New Jersey, specializes in gene synthesis, gene editing, custom protein and...
- This firm fixed price delivery order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company, has a potential value of $8,163.25. The award is for peptide services and does not have a set-aside designation. Genscript is a provider of gene synthesis, gene editing, protein production, and other molecular biology services to various federal agencies, including the NIH, CDC, FDA, and...
- This federal contract was awarded by the Plains Area division of a civilian federal agency to Genscript USA Inc., a biotechnology company based in New Jersey. The $3,458.11 firm fixed-price purchase order is for protein expression and purification services. The contract does not have a set-aside designation. Genscript has received numerous prime and subcontract awards from federal agencies like the Department of Health and Human Services (including the National Institutes of Health, Centers...
The U.S. government awarded a $3,681.17 firm fixed-price purchase order to Genscript USA Inc. for protein synthesis services on April 8, 2019, with a completion date of May 31, 2019. The contract was issued by a civilian federal agency within the Pacific West Area and will be performed at Genscript's headquarters in Piscataway, New Jersey. No set-aside designation was applied to this award, making it available to all qualified vendors in full and open competition. Genscript USA Inc., a biotechnology company specializing in molecular biology services, has been a registered federal contractor since July 2013 and regularly supports government agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, and Department of Agriculture. The company's core competencies include gene synthesis, protein production, antibody development, and custom biological research materials. This particular purchase order for protein synthesis represents a routine procurement within Genscript's established service portfolio supporting federal research and public health initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 4/8/19 |